Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.70B | 1.82B | 1.43B | 1.17B | 959.22M |
Gross Profit | ||||
296.69M | 201.03M | 184.28M | 128.73M | 166.23M |
EBIT | ||||
-101.56M | -127.82M | -128.64M | -178.07M | -6.00M |
EBITDA | ||||
-77.44M | -105.30M | -113.53M | -161.81M | 9.47M |
Net Income Common Stockholders | ||||
-128.03M | -148.02M | -149.64M | -212.96M | -39.13M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
470.65M | 318.82M | 409.55M | 466.60M | 207.31M |
Total Assets | ||||
782.06M | 591.88M | 633.86M | 630.89M | 338.50M |
Total Debt | ||||
7.83M | 170.79M | 164.60M | 157.59M | 154.44M |
Net Debt | ||||
-425.02M | -32.12M | -244.95M | -309.00M | -52.87M |
Total Liabilities | ||||
681.11M | 433.81M | 394.56M | 324.84M | 307.89M |
Stockholders Equity | ||||
99.85M | 156.95M | 238.13M | 306.04M | 30.61M |
Cash Flow | Free Cash Flow | |||
-6.65M | -95.18M | -69.20M | -97.14M | -8.15M |
Operating Cash Flow | ||||
34.77M | -59.19M | -45.43M | -78.78M | 7.56M |
Investing Cash Flow | ||||
39.19M | -147.26M | -28.22M | -20.82M | -16.36M |
Financing Cash Flow | ||||
156.03M | 105.00K | 16.59M | 360.13M | 130.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $29.78B | 9.61 | 12.65% | ― | 5.89% | 27.09% | |
69 Neutral | $3.33B | ― | 2.80% | ― | 56.54% | ― | |
67 Neutral | $31.93B | 26.50 | 7.40% | 1.34% | 10.70% | -49.85% | |
65 Neutral | $472.03B | 33.28 | 15.88% | 1.58% | 8.35% | -35.14% | |
61 Neutral | $3.51B | ― | -99.72% | ― | 48.25% | 15.42% | |
49 Neutral | $6.85B | 0.81 | -52.91% | 2.50% | 19.94% | 1.20% | |
45 Neutral | $1.83B | ― | -14.75% | ― | -32.45% | 80.24% |
Alignment Healthcare announced the promotion of Dawn Maroney to President, where she will oversee day-to-day operations, focusing on enhancing member experiences and ensuring seamless execution across markets. The company reported a significant 35% year-over-year growth in health plan membership to approximately 209,900 as of January 1, 2025, and projects membership to rise to 225,000-231,000 by year-end 2025. Alignment Healthcare reaffirmed its full-year 2024 financial guidance and expressed confidence in achieving a consensus adjusted EBITDA of $40 million in 2025. The company continues to expand its market reach and maintain high ratings for its plans, demonstrating robust growth and operational excellence.